Home |
Free Dividend Report |
Stock Splits Calendar |
CLVS Historical Stock Prices |
Preferred Stock Newsletter |
CLVS Options Chain |
Stock Message Boards |
Clovis Oncology (CLVS) has the following price history information. Looking back at CLVS historical stock prices for the last five trading days, on December 14, 2022, CLVS opened at $0.14, traded as high as $0.14 and as low as $0.10, and closed at $0.11. Trading volume was a total of 24.44M shares. On December 15, 2022, CLVS opened at $0.11, traded as high as $0.11 and as low as $0.09, and closed at $0.10. Trading volume was a total of 15.67M shares. On December 16, 2022, CLVS opened at $0.10, traded as high as $0.11 and as low as $0.08, and closed at $0.08. Trading volume was a total of 22.99M shares. On December 19, 2022, CLVS opened at $0.08, traded as high as $0.09 and as low as $0.08, and closed at $0.09. Trading volume was a total of 19.78M shares. On December 20, 2022, CLVS opened at $0.08, traded as high as $0.10 and as low as $0.08, and closed at $0.08. Trading volume was a total of 24.40M shares.
CLVS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Clovis Oncology shares, starting with a $10,000 purchase of CLVS, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/28/2014 | |
End date: | 12/20/2022 | |
Start price/share: | $51.81 | |
End price/share: | $0.08 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.85% | |
Average Annual Total Return: | -52.68% | |
Starting investment: | $10,000.00 | |
Ending investment: | $15.43 | |
Years: | 8.65 |
CLVS Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
12/14/2022 | $0.14 | $0.14 | $0.10 | $0.11 | 24.44M |
12/15/2022 | $0.11 | $0.11 | $0.09 | $0.10 | 15.67M |
12/16/2022 | $0.10 | $0.11 | $0.08 | $0.08 | 22.99M |
12/19/2022 | $0.08 | $0.09 | $0.08 | $0.09 | 19.78M |
12/20/2022 | $0.08 | $0.10 | $0.08 | $0.08 | 24.40M |
About Clovis Oncology |
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. Co. markets Rubraca®, which is an oral small molecule inhibitor of poly ADP-ribose polymerase for indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Co.'s product candidates include: FAP-2286, a peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein; and Lucitanib, an oral potent angiogenesis inhibitor which inhibits vascular endothelial growth factor receptors 1 through 3, platelet-derived growth factor receptors alpha and beta and fibroblast growth factor receptors 1 through 3. |
CLVS Historical Closing Prices | |
Date | Close |
12/14/2022 | $0.11 |
12/15/2022 | $0.10 |
12/16/2022 | $0.08 |
12/19/2022 | $0.09 |
12/20/2022 | $0.08 |
Healthcare Historical Prices |
CLVS is categorized under the Healthcare sector; below are some other companies in the same sector:
CMD Historical Stock Prices Also explore: CLVS shares outstanding history
Free CLVS Email Alerts:
|
CLVS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.